Tirzepatide vs Ozempic: Which Is Better for Weight Loss?

By Verum Health Medical Team · April 1, 2026 · 8 min read

Both tirzepatide and semaglutide (Ozempic/Wegovy) are prescription GLP-1 medications that have transformed weight loss medicine. But they work differently — and the clinical results show meaningful differences in outcomes.

The Key Difference: Single vs. Dual Agonist

Ozempic/Wegovy (semaglutide) is a GLP-1 receptor agonist — it activates one receptor that reduces appetite and slows gastric emptying.

Mounjaro/Zepbound (tirzepatide) is a dual GIP + GLP-1 receptor agonist — it activates two receptors. The addition of GIP (glucose-dependent insulinotropic polypeptide) appears to significantly enhance weight loss and metabolic effects.

Clinical Results: Head-to-Head

Which Should You Choose?

• Choose tirzepatide if: You want maximum weight loss, have type 2 diabetes or insulin resistance, or haven't responded adequately to semaglutide
• Choose semaglutide if: You're new to GLP-1 therapy, prefer a more established track record, or are working with a tighter budget (semaglutide is slightly less expensive)

Pricing at Verum Health

• Semaglutide: $80–$350/month depending on dose
• Tirzepatide: $170–$750/month depending on dose

Both are available as compounded prescriptions through our licensed 503A pharmacy partner. See our full Semaglutide Protocol page for details.